A study comparing efficacy of three different injectable drugs for the treatment of keloids
Not Applicable
Completed
- Conditions
- Health Condition 1: null- Keloids
- Registration Number
- CTRI/2017/05/008646
- Lead Sponsor
- Sawai Man Singh Medical College Jaipur
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 60
Inclusion Criteria
keloids of size 1 to 10 cm in greatest dimension,
keloids of >6 months duration
Exclusion Criteria
Hypertrophic scars,
Females who were pregnant or were planning pregnancy,
Patients who had received treatment for the same keloid in the past 12 months,
Patients who had active inflammation, infection or ulcer in or around the keloid,
Immunosuppressed patients,
Patients with chronic inflammatory diseases,
Patients with renal or liver failure
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Keloid height, vascularity, pliability and pigmentation using Vancouver Scar scale <br/ ><br>Pain <br/ ><br>PruritusTimepoint: Every 3 weeks for 24 weeks and 30 weeks after first dose
- Secondary Outcome Measures
Name Time Method Keloid height, vascularity, pliability and pigmentation using Vancouver Scar scale <br/ ><br>Pain <br/ ><br>PruritusTimepoint: 30 weeks after first dose